dr. backes discusses her experience with parp inhibitors in ovarian cancer
Published 4 years ago • 183 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
1:11
dr. backes discusses parp inhibitor combinations in ovarian cancer
-
1:37
dr. backes on financial toxicity considerations in ovarian cancer
-
1:11
dr. berek discusses the impact of parp inhibitors on ovarian cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
6:35
parp inhibitor side effect management in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
2:03
dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
0:46
dr. chase on toxicities with niraparib in ovarian cancer
-
2:22
dr. konecny on the value of parp inhibitors in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
6:20
parp inhibitors in recurrent ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
2:26
dr. mirza discusses niraparib dose modifications for ovarian cancer patients with low body weight
-
1:41
dr. parsons discusses the role of parp 7 in overall survival of patients with ovarian cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer